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Abstract
Malignant pleural effusions (MPEs) could represent an excellent source to culture a wide variety of cancer cells from
different donors. In this study, we set up culture conditions for cancer cells deriving from MPEs of several patients affected
by the most frequent form of lung cancer, namely the subset of non small cell lung cancers (NSCLC) classified as Lung
Adenocarcinomas (AdenoCa) which account for approximately 40% of lung cancer cases. AdenoCa malignant pleural
effusions gave rise to in vitro cultures both in adherent and/or in spheroid conditions in almost all cases analyzed. We
characterized in greater detail two samples which showed the most efficient propagation in vitro. In these samples we also
compared gene profiles of spheroid vs adherent cultures and identified a set of differentially expressed genes. Finally we
achieved efficient tumor engraftment in recipient NOD/SCID mice, also upon inoculation of small number of cells, thus
suggesting indirectly the presence of tumor initiating cells.
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Introduction
In recent years methodological approaches to study cancer have
been deeply influenced by two major emerging concepts: a) cancer
is not a single disease but rather a heterogeneous composition of
multiple diseases, where we are just starting to distinguish and
classify subtypes characterized by distinct genetic and epigenetic
changes and by the activation of different signal transduction
pathways and transcriptional programs [1–3]; b) the growing
importance of the cancer stem cell theory [4–9]. This claims that
cancer is originated by a population of cells with stem cell like
properties (CSCs), whose distinctive feature is their extensive
capacity of self renewal, and which sustain cancer growth through
the production of a pool of transiently amplifying expanded
progenitor cells and of terminally differentiated progenies [10–13].
The putative CSCs are themselves mostly quiescent for prolifer-
ation, are resistant to chemotherapeutic agents and therefore are
thought to be responsible for disease relapse and for the emergence
of resistance to therapies [14]. These two concepts have led
investigators to shift their focus from well established cell lines
adapted by several years in culture to primary tumors because of
the realization that a) cell lines do not reproduce the natural
heterogeneity of tumors and b) they have undergone a series
genetic and epigenetic changes following years of adaptation in
culture and do not maintain the hierarchical organization typical
of the original tumor. Hence from here increasing efforts to
establish and characterize banks of primary tumors [15,16].
Although evidence has been provided that this approach can be
applied to obtain interesting correlations with clinical outcome in
solid cancers [17], its medium-high throughput implementation
suffers from several limitations. Putative CSCs are generally
present in low amounts in a given tumor tissue and proliferate
slowly; in addition very often the amount of available tumor tissue
obtained by surgery is too small. Therefore the proportion of
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fide putative CSCs is generally low and only in a subset of cases
these cells are capable of engraftment in vivo [18–20]. This has led
to the development of methods to enrich for subpopulations of
cells with increased tumorigenic potential using either surface
markers such as CD133 [9] or CD44 [21]; functional activities
such as alhedyde dehydrogenase (ALDH) staining or Hoechst
33342 exclusion [22,23]; or also in vitro culture systems in
suspension as spheroids in well defined medium conditions [24],
followed by the demonstration that engraftment of small amounts
of cells in recipient mice is able to regenerate a complete tumor
tissue resembling histologically and functionally the originating
human tumor. Although there is no general consensus about the
best combination of surface markers to use, it is common belief
that an enrichment step is helpful for the efficient establishment of
tumors in vivo [25,20].
Lung cancer is the leading cause of cancer mortality in the
world. Current therapy is relatively ineffective and survival rate at
5-years remains only 15% for advanced disease [26]. Malignancy
is one of the main causes of pleural effusions, and 90% of
malignant pleural effusions (MPEs) are due to metastatic disease
[27,28]. Carcinomas of any organ can metastasise to the pleura,
but the most frequent ones are lung carcinomas. Very recently a
limited number of studies have demonstrated that MPEs could be
an excellent source of tumor initiating cells, because they are
capable to efficiently propagate in vitro and in vivo, and to
reproduce the natural heterogeneity of tumors. One of these
studies analyzed malignant pleural effusions from breast cancer,
the other pleural effusions from a small set of heterogenous lung
cancers. Interestingly, Grimshaw et al. demonstrated that the
ability to induce tumors appeared to correlate with the ability to
produce large spheres, but not with a particular expression of
known surface markers [20,29,30]. We collected a set of samples
and assessed their ability to give rise to adherent vs non adherent
spheroid cultures without applying prior enrichment for surface
markers. By analyzing the global pattern of gene expression we
also started to derive a signature distinctive of spheroid vs adherent
AdenoCa cultures. Finally we demonstrated efficient engraftment
in vivo in mice and the establishment of tumors which reproduce
the histological features of the primary human tumors.
Materials and Methods
Sample collection, processing and cultures
We selected 15 cases of malignant pleural effusion obtained
from patients with lung adenocarcinoma at the Department of
Thoracic Surgery, University of Rome La Sapienza, Sant’Andrea
Hospital. After thoracentesis, all specimens were received as fresh
effusion, usually within one hour following collection, with
volumes ranging from 40 to 1,500 ml. After centrifugation for
5 min at 1,500 rpm, the supernatant was decanted and the
sediment resuspended in 30 ml of CytoLyte Solution (Cytyc
Corp., Massachusetts, USA). The specimen was then recentrifuged
for 10 min at 1,500 rpm and the sediment resuspended in 20 ml
of PreservCyt solution (Cytyc Corp.). A monolayer slide was made
using the Thin Prep 2000 Processor (Cytyc Corp.). From each
specimen, 5–10 slides were prepared. Of these, 1 or 2 were stained
using the Papanicolaou method, and viewed independently to
confirm the diagnosis and presence of cells suitable for evaluation.
Tumor type was determined according to cytomorphology
parameters: solitary and clusters of medium to large sized cells,
hyperchromatic and eccentrical nuclei, conspicuous nucleoli and
variable cytoplasmatic vacuolization. Malignant pleural fluid cells
were also submitted to immunocytochemistry in order to confirm
Adenocarcinoma cell origin. Diagnoses were considered ‘true
positives’ if they were inagreement with the consensus cytological
diagnosis.
Experiments were approved by the Sant’ Andrea Hospital
Ethics Committee 2010 (504/10). All patients agreed to participate
to the study and signed an informed consent form.
To partially purify tumor cells, cells from Malignant Pleural
Effusion (MPE) were subjected to discontinuous density gradient
centrifugation as follows. MPE, obtained aseptically in heparinized
(10 U/ml) bottles and processed within a reasonable time (4 hr),
were centrifuged at 300 g for 10 min, at 4uC and cell pellet was
resuspended in 30 ml of cold 1% BSA/2 mM EDTA/PBS. Cells
were counted in a haemocytometer by Trypan Blue exclusion dye
(Sigma-Aldrich) and then cell suspension was layered on modified
Histopaque-1077 (Sigma-Aldrich) modified gradient in 50 ml
conical tube (Falcon). Histopaque-1077 solution of a density of
about 1,065 gr/ml was obtained by diluting it with Phosphate
Buffered Saline pH 7,2. Discontinuous gradient was then
centrifuged at 800 g, for 30 minutes, at room temperature.
During the centrifugation step the cells were separated according
to their different buoyant densities: the denser fluid components
such as erythrocytes and some leucocytes migrate into the lower
phase through the bottom of the tube while the less dense cell
fraction, including tumor cells, are enriched at the interphase.
After centrifugation, cells contained in the upper gradient and in
the pellet were collected and washed once with 1%BSA/2 mM
EDTA/PBS. Cells from the upper gradient were then plated in
‘‘Sphere Medium’’ at a concentration of 100’000 cells/ml in non-
tissue culture treated plates (Falcon) or Ultralow binding plates
(Corning). Half volume medium was replaced once a week while
growth factors (bFGF and EGF) were added every other day. The
pellet from density gradient centrifugation, which contains
leucocytes, erythrocytes and clumps of tumor cells, was subjected
to hypotonic lysis to remove erythrocytes, washed once in 10%
FCS-RPMI (Invitrogen) and then plated in tissue culture treated
Petri dishes (Falcon).
To determine their self renewal ability, sphere propagation
assay were performed: adherent lung cancer cells were mechan-
ically dissociated and plated in non-adherent culture to form P0
spheres. After 6–12 days individual spheres were formed,
dissociated with Accumax and serial dilution was used to replate
an average of 1 cell per well in 96-well plates to generate P1
spheres. This procedure were repeated several up to 3–4 times.
ALDH activity assay
Cells growing in adherent or spheroid conditions, were
collected, dispersed by Accumax (Innovative Cell Technologies,
Inc. San Diego, CA) treatment, and 0.5–1610
6 cells analyzed for
ALDH1 activity using ALDEFLUOR kit (Stem Cell Technologies)
following manufacturer instruction. Briefly, cells were suspended
in ALDEFLUOR assay buffer containing the fluorescent ALDH1
substrate, BODIPY-aminoacetaldehyde (BAAA), and incubated
for 45 min at 37uC. The assay buffer contains also a transport
inhibitor, to prevent efflux of the BAAA from the cells. BAAA
passively diffuse into live cells and then is converted by
intracellular ALDH1 into a negatively charged product BOD-
IPY-aminoacetate, which is retained inside cells, labeling them
with a bright fluorescent signal. After a washing step, the brightly
fluorescent ALDH1-expressing cells (ALDH1
br) were detected in
the green fluorescence channel (FL1; 520–540 nm) of a FACSCa-
libur instrument (BD Biosciences). A sample of cells were stained
as above with the addition of a specific ALDH1 inhibitor,
diethylaminobenzaldehyde (DEAB) (Sigma), to serve as a negative
control for each experiment. Because only cells with an intact
Tumor Spheroids from AdenoCa Pleural Effusions
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only viable ALDH1br cells were identified. Cells incubated with
BAAA and DEAB were used to establish the background signal
and to define the ALDH1
br region. Incubation of cells with the
substrate in the absence of DEAB induced a shift in BAAA
fluorescence defining the ALDH1
br population. Data were
analyzed by FCSExpress.
Microarray Analysis
Single strand biotinylated cDNA was generated as follows:
100 ng of total RNA were subjected to two cycles of cDNA
synthesis with the Ambion WT expression Kit (Applera). The first
cycle – first strand synthesis is performed using an engineered set
of random primers that exclude rRNA-matching sequences and
include the T7 promoter sequences. After second-strand synthesis,
the resulting cDNA is in vitro transcribed with the T7 RNA
polymerase to generate a cRNA. This cRNA is subjected to a
second cycle – first strand synthesis in the presence of dUTP in a
fixed ratio relative to dTTP. Single strand cDNA is then purified
and fragmented with a mixture of uracil DNA glycosylase and
apurinic/apirimidinic endonuclease 1 (Affymetrix) in correspon-
dence of incorporated dUTPs. DNA fragments are then terminally
labeled by terminal deoxynucleotidyl transferase (Affymetrix) with
biotin. The biotinylated DNA was hybridized to the Human
Genechip Gene 1ST Arrays (Affymetrix), containing almost 29000
genes selected from H. sapiens genome databases RefSeq,
ENSEMBL and GenBank. Chips were washed and scanned on
the Affymetrix Complete GeneChip Instrument System, generat-
ing digitized image data (DAT) files.
Data files were analyzed with AGCC (Affymetrix, Santa Clara,
CA) producing CEL files. Robust multichip average (RMA)
normalization and data analysis were performed using Gene-
Spring 11.0.2 (Agilent Technologies, Santa Clara, CA). Time
analysis among the different stages of the same culture was
performed using CAGED (Cluster Analysis of Gene Expression
Dynamics) which identifies the most probable set of clusters given
a set of time series [31]. The culture identified as PE e/10 has 6
time points, therefore, according to CAGED’s recommendations
for short time series, we used the Polynomial Model approach
(Model Order=3, Prior Precision 1, Gamma Value=0, Bayes
Factor=1, Distance=Euclidean). We obtained 12 clusters,
however only one showed a significant variation over time. This
cluster, containing 69 probesets, was functionally annotated by
Gene Ontology (GO) for Biological Process. Enriched GO terms
(i.e. terms with a significantly higher than expected number of
associated genes) were filtered (p#1*10
22) by the Hypergeometric
test and corrected using False Discovery Rate (FDR). For the
analysis of gene expression profiles in adherent cultures compared
to sphere cultures, differentially expressed (DE) probe sets were
filtered for fold change $1.5. Statistical analysis was performed
using the Welch t-test, with p#0.05. DEGs were functionally
characterized using a proprietary software, Ingenuity Pathway
Analysis (IPA) from Ingenuity SystemsH to identify possible
enriched molecular networks and canonical pathways. From the
29000 genes on the chip we obtained 1494 differentially expressed
probe sets for the patient PE d/10 and 171 differentially expressed
probe sets for the patient PE e/10. At this point we generated the
intersection list of the two samples composed by 82 probe set. As a
further filtering step, we generated a list of probes with similar
behavior in the two samples by considering just those genes with a
FC lower than 1.5 between the two adherent cultures. In this way
we produced a curated list of 54 DE probe sets. The accession for
experimental submission is MIAMExpress database number E-
MEXP-3025.
Quantitative RT-PCR (pRT-PCR)
Using Primer3 software analysis available on the web, we
selected primer sequences to optimally amplify target for qRT-
PCR assay. To avoid possible amplification of contaminating
genomic DNA primers were designed so that each PCR product
covered at least one intron. All the primers used have been
synthesized by Sigma. The expression of selected genes was
examined by real-time reverse transcription-PCR (RT-PCR) using
SYBR Green Detection Chemistry (Applied Biosystem). One
micrograms of total RNA extracted from each of the samples were
used to make complementary DNA (cDNA). Twenty nanograms
of cDNA were used as template for qPCR amplification in
presence of 0,2 mM specific primers, in a total volume of 25 ml.
PCR reactions without cDNA samples were used as negative
controls. Each reaction was done in triplicate and repeated at least
twice to verify the results. SDS system software (Applied
Biosystems, Foster City, CA) was used to convert the fluorescent
data into cycle threshold (Ct) measurements and the relative
amount of specific transcript was calculated by the comparative
cycle threshold method given by [32–33]. All values of RNA
accumulation of the specific genes were normalized to the signal of
GAPDH and HPRT in each sample and plotted for comparison of
the relative amounts of the transcripts. Statistical analyses were
performed using the SPSSH computer program package (SPSS for
Windows, version 11.5). Frequency tables were analysed using t-
Student’s correlation coefficient. The statistical significance was set
at P,0.05.
Generation of subcutaneous and orthotopic lung cancer
xenografts into NOD/SCID mice
Two-month-old male NOD/SCID mice (Charles River,
Margate, Kent, UK) were used. Animals were anesthetized with
ketamine and injected with 10
4 cells subcutaneously and with
2610
3 cells intra lung. Mice were housed in a highly controlled
microbiological environment to guarantee SPF conditions. They
were maintained in IVC cages, under constant conditions of
temperature (2262uC), humidity (55%610 UR) and light/dark
cycle of 12/12 hours. The animals had free access to irradiated
standard diet and water.
Cells obtained by detachment from PE d/10 and PE e/10
adherent or spheres cultures dissociated to obtain single cell
suspension, were diluted in 16 PBS plus 50% matrigel before
subcutaneous injection. Mice were daily monitored to avoid any
sign of suffering and weekly to check for the appearance of
subcutaneous tumor or weight loss due to potential tumor growth.
When subcutaneous tumors volume reached at least 700 mm
3 in
size, the tumor mass was excised, collected and submitted to
histological analysis. In a subset of cases tumors were minced into
small pieces and transplantated into a second recipient NOD/
SCID mouse. In absence of additional signs of pathology groups of
mice were euthanized every two months in order to check for the
presence of lung cancer metastasis. At animal sacrifice, a complete
necropsy procedure was performed. Cervical, thoracic, abdomi-
nal, and pelvic organs were extracted en bloc. We assessed the
development of local tumor at the injection site, measured its two
largest diameters, and recorded all macroscopic tumor deposits or
abnormalities in any organ, especially those in which lung cancer
foci were expected (pleura, lymph nodes, liver, and brain). The
whole block of organs was fixed with buffered formalin for 48 h,
except for the lung. The lungs were excised and the tumor
removed, weighed, fixed with 10% formalin in PBS. Two general
pathologists analyzed histopathologically the tumor at the injection
site. All the experimental procedures were approved by the Ethical
Tumor Spheroids from AdenoCa Pleural Effusions
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communicated to the Italian Ministry of Health.
Immunocytochemistry and NOD/SCID mice
immunohistochemistry
PE d/10 and PE e/10 were submitted to cytospins using 100000
cells per spot, centrifuged at 800 rpm for 3 minutes. The slides
were allowed to dry over night and fixed with Acetone or
Formaldheyde 4% for intracitoplasmatic antigens or membrane
antigens, respectively. Cytospins were washed in PBS tween20
0.05%. Blocking reagent followed by primary antibody and then
biotinylated anti-mouse secondary antibody were added. The
primary antibody used was an anti-CK7 (DAKO Cytomatic), anti-
BerEP4 (DAKO Cytomatic) anti-Vimentin (Novocastra) and
ALDH 1a1 (Epitomics). After a further step of washing in PBS
tween 20 0.05%, slides were treated with avidin-biotin complex for
30 min using DAKO Cytomatic LSAB+Syste-HRP detection
system according to the manufacturers instructions. Staining was
performed with 3,39-diaminobenzidin and counterstaining with
HE. The primary antibodies were omitted and replaced with
Table 1. Clinicopathological features of pleural effusion cases.
Case n6 Sex Age Primary site T N M P-Stage Survival RPMI Sphere Medium
PE a/10 F 77 RUL 4 3 1a IV 4 yes no
PE b/10 M 81 RLL 4 2 1b IV 1 yes yes
PE c/10 F 85 RLL 4 3 1a IV 11 yes No
PE d/10 M 64 RIL 4 3 1a IV 0 yes Yes
PE e/10 F 52 LLL 4 1 1a IV 0 yes Yes
PE f/10 M 76 RUL 4 2 1a IV 14 yes No
PE g/10 F 63 LLL 4 3 1b IV 4 yes Yes
PE h/10 M 78 RML 4 2 1a IV 6 yes Yes
PE i/10 M 66 RML 4 3 1a IV 4 yes Yes
PE l/10 M 77 LLL 4 2 1a IV 6 yes Yes
PE lm10 M 57 LLL 4 2 1a IV 3 yes Yes
PE n/10 F 51 LUL 4 3 1a IV 0 yes No
PE o/10 M 56 RLL 4 1 1a IV 11 yes Yes
PE p/10 M 77 RUL 4 2 1a IV 2 yes Yes
PE q/10 M 63 RUL 4 2 1a IV 26 yes Yes
Patient characteristics and culture performances of adenocarcinoma cells from pleural effusions in MPE, RPMI and SFM medium conditions.
doi:10.1371/journal.pone.0021320.t001
Figure 1. a: In the upper panel a sample picture of PE d/10 and PE e/10 cell culture grown in adherence in RPMI medium in presence
of serum; b: in the lower panel the same primary cultures grown in non-adherent conditions supplemented with growth factors
(bFGF and EGF) (2006).
doi:10.1371/journal.pone.0021320.g001
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adopted based on the manufacturer’s instructions.
Sections 3 mm thick from Xenograft mice tumor were cut onto
silanized glass slides and air-dried overnight at room temperature.
Sections were dewaxed in xylene and rehydrated through graded
alcohol. After peroxidase inhibition, the sections were immersed in
citrate buffer (pH6.0) (Zymed, San Francisco, CA, USA) and
irradiated twice in a microwave oven (800W) at full power for
15 min. After, the slides were incubated with the following
antibodies: anti-CK7 (DAKO Cytomatic), anti-BerEP4 (DAKO
Cytomatic) anti-Vimentin (Novocastra). After a further step of
washing in PBS, slides were treated with avidin-biotin complex for
30 min using Dako Cytomation LSAB+Syste-HRP detection
system according to the manufacturers instructions. Staining was
performed with 3,39-diaminobenzidin. and counterstaining with
HE. At least 100 cells per view were counted. Cases were
considered positive if at least 10% of cells were strongly stained for
the antibody. The primary antibodies were omitted and replaced
with preimmune serum in the negative control. Positive controls
were adopted based on the manufacturer’s instructions.
Results
Lung adenocarcinoma cells isolated from malignant
pleural effusions give rise to primary cultures
Malignant pleural effusions were collected by thoracentesis as
described in the Materials and Methods section and as previously
reported [34]. All samples were subjected to cytological and
immunocytochemistry analysis (see Materials and Methods). We
decided to establish primary cultures only of samples diagnosed
cytologically as lung adenocarcinomas.
All samples, grew in RPMI medium in the presence of 10% FBS
although, as expected, a great variability from sample to sample was
Figure 2. Showed the presence of PE e/10 percentage of ALDH
br cells which are increased upon culturing in spheroid conditions,
providing information about the presence of putative CSC in MPE primary cultures.
doi:10.1371/journal.pone.0021320.g002
Table 2. FACS analysis of ALDH activity.
MPE cultures
Adherent
+DEAB 2DEAB
Floating
+DEAB 2DEAB
PE d/10 0.2% 1.1% 0.2% 3.3%
PE e/10 0.2% 0.7% 0.2% 6.0%
PE g/10 0.18% 5.2% 0.2% 5.1%
PE h/10 0.2% 2.1% 0.2% 7.5%
PE i/10 0.21% 1.5% 0.18% 4.8%
PE l/10 0.2% 1.7% 0.2% 5.3%
Primary cultures grown in adherent or sphere conditions have been analyzed
by FACS for ALDH activity using ALDEFLUOR assay. All samples, in adherent or
sphere conditions, were incubated with or without ALDH inhibitor, DEAB, to
determine baseline fluorescence.
doi:10.1371/journal.pone.0021320.t002
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experiments showing p,0.05 statistical analysis.
doi:10.1371/journal.pone.0021320.g003
Figure 4. Bioinformatic analysis. a) PCA analysis on adherent culture PE d/10 (red), PE e/10 adherent culture (blue) and sphere culture (brown); b)
Venn Diagram of the two adherent cultures showing 82 probesets in the Intersection; c) Gene expression profiles of the Curated list; d) Venn Diagram
of the Curated list, Intersection list and DE probeset list of H460 cells.
doi:10.1371/journal.pone.0021320.g004
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(not shown). In order to avoid long periods of adaptations in cell
culture that may lead to the selection of subpopulation of cells with
particular growth advantages all samples were banked in liquid
nitrogen at passage 3 (p3), on average one month following MPE
collection. All further studies were conducted with p4 to p6 cells, i.e.
cells in the initial passages after thawing, unless otherwise specified.
p4 cells all re-grew in adherence. When they were transferred into
sphere forming medium (SM), i.e. DMEM/F12 medium supple-
mented with EGF and FGF, the majority ofsamples, i.e. 11 out of 15
(Table 1), produced spheres propagating through some passages,
although, also in this case, significant variability was observed among
samples with respect to the sphere forming unit ability and sphere
size. Some examples are shown in Figure 1:s a m p l eP Ed / 1 0g r o w s
in adherence as cells with epithelial shape forming a cobblestone-like
monolayer and as large irregular spheroids in sphere medium
(Figure 1a). In contrast, in the case of sample PE e/10, cells grew in
large clusters in part also made of cells with elongated and
fibroblastoid shape in RPMI condition, but form tinier and very
compact spheres in sphere medium condition (Figure 1b).
In order to demonstrate the presence in primary cell line PE d/
10 and PE e/10 of CSCs in our spheroid cultures we set up self
renewal assays (see Materials and methods section). Primary
spheres were dissociated with Accumax and single cells seeded in
96-well plates. After 6–12 days we observed the formation of
individual spheres (Figure S1). This procedure was repeated
successfully at least 2 times showing, however, a gradual decrease
in the frequency of sphere formation up to passages 3–4.
AdenoCa spheroids from MPEs overexpress stem cell
markers
Cancer Stem Cells (CSC) are single tumor cells which are
thought to be capable to regenerate a tumor or a metastasis. The
identificationofCSCremainschallenging and severalCSCmarkers
have been proposed. Among several, ALDH1 expression and its
enzymatic activity seems to better correlate presence of CSC and
aggressiveness of lung tumors [35]. Isolated ALDH1-positive cells
from stable cell lines showed features of CSC and overexpression of
ALDH1 has been correlated with poor prognosis for patients with
early-stage NSCLC [22]. Primary cultures obtained from MPEs
were characterized for the presence of cells with ALDH1 activity by
FACS analysis; both in adherent and spheroid culture. Results
(Figure 2 and Table 2) show that in the majority of samples
analyzed the percentage of ALDH
br cells increased upon culturing
in spheroid conditions, providing information about the presence of
putative CSC in MPE primary cultures.
Moreover, the expression level of stem cell markers connected to
self-renewaland stemness cabability was evaluated.To this purpose,
we examined Oct-4, Nanog, Notch3 and Stat3 at level of
transcription in RNA extracted from adherent vs shperoids of
samplePEd/10.The amountsoftheindicated transcripts,analyzed
by real-time RT-PCR, were significantly increased in cell grown as
spheres compared with those grown in adherence (Figure 3).
A small subset of genes is differentially co-regulated in
sphere vs adherent cells
In the previous sections we have shown that lung AdenoCa
MPEs give rise with efficiency to cell cultures which are able to
grow in adherent conditions and as spheroids. For the rest of our
study we focussed our attention on two samples, i.e. PE d/10 and
PE e/10 that were among the most efficient in in vitro propagation.
Morphological and immunocytochemistry examination of these
cultures over passages (p4 to p 10) did not reveal any substantial
change (not shown). In order to better evaluate possible changes
taking place over time in culture, RNA samples was extracted
from adherent cultures of sample PE d/10 at passages 6, 8, 10, 13,
14 and 16 and subjected to expression profiling. We utilized
CAGED an algorithm based on Bayesian Clustering by Dynamics
(see Methods section), which performs Bayesian clustering on
temporal gene expression data to search for the most probable
set of clusters given the available data. The majority of gene
clusters showed a virtually flat behaviour over time, thus
confirming an overall stability of gene expression (not shown).
Only one small cluster made by 69 probesets showed a moderately
raising expression profile over time. (Table S1). When this cluster
was functionally annotated by Gene Ontology (GO) for Biological
Process (p#1*10
22) we obtained 9 Biological Process GO
categories enriched in the PE d/10. Interestingly the GO
categories enriched in the PE d/10 are related to ‘‘DNA
conformation changes’’ as reported in the supplementary (Table
S2). Furthermore, we performed genome-wide microarray analysis
Table 3. Sphere vs adherent cultures co-regulation.
Transcripts
Cluster Id Genesymbol
NCI-H460 (Sphere/
Adherent) Gene
Expression
MPE Gene
Expression
7908459 CFH UP UP
8086985 COL7A1 UP UP
8051583 CYP1B1 UP UP
8140864 CYP51A1 UP UP
7950885 FZD4 UP UP
8095680 IL8 UP UP
8040695 KCNK3 UP UP
7985317 KIAA1199 UP UP
7961365 MANSC1 UP UP
8003332 MVD UP UP
8062927 PI3 UP UP
7920244 S100A8 UP UP
7905571 S100A9 UP UP
8098195 SC4MOL UP UP
7929816 SCD UP UP
7941148 TM7SF2 UP UP
7939024 TMEM16C UP UP
8028652 ZFP36 UP UP
7994582 SULT1A3 UP UP
7948667 AHNAK DOWN DOWN
8070632 CBS DOWN DOWN
7953291 CD9 DOWN DOWN
7978706 FOXA1 DOWN DOWN
7977854 JUB DOWN DOWN
8017019 MTMR4 DOWN DOWN
7984364 SMAD3 DOWN DOWN
8056545 STK39 DOWN DOWN
8093950 S100P UP DOWN
7899615 SERINC2 UP DOWN
Overlap of 29 DE genes which appear co-regulated (up-or down-regulated) in
sphere vs adherent cultures of MPEs and NCI-H460.
doi:10.1371/journal.pone.0021320.t003
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regulated between sphere cultures and adherent cells. We
compared gene expression profiles of adherent vs sphere cultures
of RNA extratcted at p6 (Figure 4a). Differentially expressed
(DE) probe sets were filtered for fold change .1.5 statistical
significance (p-value 0.05) resulting in 1494 DE probe sets for the
PE d/10 adherent culture and 171 DE probe sets for the PE e/10.
We then calculated the intersection list with a Venn Diagram
(Figure 4b) to obtain a common DE probe sets of 82 genes in
adherent vs spheres between the two patients (Table S3). To
discard genes whose expression doesn’t vary significantly between
the two adherent cultures, this DE probe set was again filtered for
fold change, this time looking for genes with a negligible variation
(fold change value lower than 1.5) between the two adherent
cultures (Figure 4c). In this way, from the initial 82 intersection
DE gene list, we obtained a curated list of only 54 DE genes
(Table S4). A bibliographic annotation on curated genes was
performed using Ingenuity Pathway Analysis (IPA), as described in
Materials and Methods. The most significant IPA Canonical
Pathways are shown in Figure S3. We finally compared the
previous 82 and 54 DE gene lists obtained from MPE primary
cultures with unpublished profiling data obtained comparing
adherent vs sphere cultures of the stable lung cancer AdenoCa cell
line NCI-H460. The results, schematically represented in the
Venn Diagram (Figure 4d), show an overlap of 29 DE genes
which appear co-regulated (up-or down-regulated) in sphere vs
adherent cultures of MPEs and NCI-H460 (Table 3). If only the
curated gene list is considered, the overlap with NCI-H460
spheres vs adherent is reduced to only 18 genes. In order to start
validating these results we carried out qPCR analysis of 8 selected
genes from the 18 DE gene list (Figure 5). qPCR results
confirmed the fidelity of the array analysis. Remarkably we
obtained more consistent fold changes in RNA levels compared
with the Array Expression Profile for all of the selected genes, in
normalizations with two different housekeeping genes (GAPDH/
HPRT). Therefore, the qPCR results confirm the accuracy of the
Array analysis in determining differential gene expression profile
of the cell growth in two different conditions, RPMI and SM.
Pleural effusion adherent and spheroids cell derived are
more efficient than cultures in the establishment of
tumor growth in vivo in NOD/SCID mice
The best way to assess the presence of tumor initiating cells in a
lung tumor cell culture sample is the demonstration of the ability
to form tumors when implanted in vivo by transthoracic or
subcutaneous puncture in NOD/SCID mice. For this reason we
carried out engraftment studies with cells derived from PE d/10
and PE e/10 at passage p6. We injected a constant number of
cells, namely 10
4 for subcutaneous (s.c.) and 2610
3 for orthotopic
injections respectively. Results indicate that both adherent and
spheroids cultures engrafted very efficiently s.c. A compendium of
Figure 5. Results of qPCR analysis of 8 selected genes from the 18 DE gene list, confirming the fidelity of the array analysis
(p,0.05). Expression Profile for all of the selected genes, in normalizations with two different housekeeping genes (GAPDH/HPRT).
doi:10.1371/journal.pone.0021320.g005
Table 4. Characterization of generated tumors.
No. of tumor cells
inoculated
No. of subcutaneous
tumors
Tumor
volume (mm3)
Tumor
Weight (gr)
Latency
(weeks)
PEe/10 adherent 1610
4 5/6 1571.2 Ds 1013,3 20.7 12
PEd/10 adherent 1610
4 4/6 1786.2 Ds 980,5 29.3 14
PEe/10 spheroid 1610
4 13/16 1817.2 Ds 851,4 21.2 12
PEd/10 spheroid 1610
4 6/6 2538.1 Ds 1617,7 29.2 10
Table shows the number of inoculated cell and tumor developed in subcute with their characteristic of volume, weight and latency.
doi:10.1371/journal.pone.0021320.t004
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Almost all injected mice developed large tumors (Figure S2) with
a variable latency time of about 10–16 weeks (Table 4). We
achieved also serial transplantation of one tumor from PE d/10
and one from PE e/10 (Table 5). Interestingly, secondary tumors
appeared after a much shorter latency time, thus suggesting an
increase in the number of tumor initiating cells after the first
passage in mice. A more limited number of orthotopic injections
were performed; in this case we observed that only spheroids were
able to grow in the lung parenchyma (not shown).
All implanted mice were euthanized after tumor development.
Histological evaluation of all organs was then carried out which
revealed adenocarcinoma lesions only in lung and subcutaneous
tissues. Adenocarcinoma reproduced in NOD SCID mice showed
pathologic features very similar to those seen in original human
tumors; both xenografts and primary tumors were characterized
by the presence of pleomorphic tumor cells with a predominantly
solid pattern of growth (Figure 6). Immunohistochemical
evaluation of CK7, BerEp4 and Vimentin markers expression
was carried out on all xenograft lesions and on the spheroid cells
before injection (Figure 7). All spheres showed strong expression
of CK7 and BerEp4, and a weak staining for Vimentin.
Subcutaneous and lung xenografts showed CK7 and BerEp4
immunoreactivity in all cases; none showed Vimentin expression.
A final intriguing observation was that, in line with what observed
in vitro, tumors developing upon adherent culture injections
maintained in vivo a lower percentage of ALDH+ cells than their
counterparts obtained upon spheroid injections (Figure 8).
Discussion
The present study confirms and expands recent observations
showing that Malignant Pleural Effusions (MPEs) obtained from
lung cancer patients are a source of cancer initiating cells and may
Table 5. Characterization of tumors after transplantation.
Number of
subcute tumors Transplantation Immunohistochemistry
Tumor volume
(mm3)
Tumor weight
(gr)
Latency
(Weeks)
PE e/10 3 Subcutaneous Identical to parental tumors 1021.5 23.1 6
PE d/10 3 Subcutaneous Identical to parental tumors 971.7 22.4 5
Table shows numbers of tumors transplanted, site of transplantation, immunohistochemistry patterns, volume, weight and latency.
doi:10.1371/journal.pone.0021320.t005
Figure 6. Immunophenotipic characteristics of human adenocarcinoma spheres and matched tumors generated in NOD SCID mice.
Immunostaining for Ber-Ep4, CK 7 and Vimentin showed Ber-Ep and CK 7 protein expression in both spheres and xenografts; in contrast, a weak
Vimentin expression was observed in cytological specimens only.
doi:10.1371/journal.pone.0021320.g006
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heterogeneity [29]. Differently from the prior study reported in
literature, we have decided to focus on samples derived from the
most common form of NSCLC, namely Lung AdenoCa, and to
assess their propagation in vitro using two different culture
conditions. The first interesting observation is that MPE cell
cultures maintain viability and are capable of propagation for
some passages with high efficiency. As expected, morphology,
duplication time, and length of duration in culture differs
significantly from sample to sample, but the main observation is
that a high proportion of samples is able to grow both as adherent
and as spheroid cultures and can be banked for further studies.
We have decided to focus our attention on the two samples, PE
d/10 and PE e/10 that were most efficient in propagation in vitro
and have started to ask the following questions: a) how is the global
pattern of gene expression changing over time in culture?; b) are
spheroid cultures enriched in markers commonly associated with
stemness and do they differ from adherent cultures in their gene
expression programs?; c) are lung AdenoCa cultures from MPEs
capable of efficient engraftment in vivo and, if so, can we observe
differences between adherent vs spheroids?
In response to the first question, we carried out morphological
and genome wide gene expression profiling using the Affimetrix
platform in sample PE e/10 over serial passages. Although we are
aware of the limitations given by the small set of samples analyzed,
the conclusion that can be drawn is that the overall gene
expression pattern in sample PE e/10 remains stable over time.
Interestingly, however, a small cluster of genes enriched for genes
involved DNA packaging and maintenance undergoes a statisti-
cally significant and gradual increase from passage 6 to 16. This
indirectly reinforce the concept that long term culture of primary
cells may lead to the occurrence of epigenetic changes. We are
currently investigating if the same trend is observed in other
samples of our collection.
In response to the second question, microarray analysis of
samples PE d/10 and PE e/10 shows that they differ substantially
in their pattern of gene expression (Figure 4a). This finding
underscores the high degree of inter-patient heterogeneity of
tumors from the same histotype. We believe that the difference
observed is due to a different complement of oncogenes mutations
and/or signalling pathways deregulations in the two samples.
Indeed, although we have not conducted a thorough mutational
analysis we have observed that while sample PE d/10 carries
activating mutations of the Ras oncogene, sample PE e/10 does
not possess a mutated Ras, but shows a prominent upregulation of
several members of the ErbB receptor family and the constitutive
activation of downstream Akt pathway (unpublished).
Since some studies have reported a higher efficiency of tumor
engraftment of spheroid vs adherent cultures [36], we have started
to look for genes that are differentially regulated. To this purpose
Figure 7. Histological features of lung adenocarcinoma xenografts. Representative histological images of H&E stained slides of primary lung
tumor (a, original magnification 6200) and corresponding subcutaneous (b, original magnification 6100) and orthotopic (c, original magnification
6200) grafts. Adenocarcinomas reproduced in NOD SCID mice showed the same morphologic pattern of the primary tumor characterized by
pleomorfic neoplastic cells arranged in solid nests.
doi:10.1371/journal.pone.0021320.g007
Figure 8. Immunohistochemistry for ALDH in subcutaneous tumor xenografts. A. Sphere implants in NOD/SCID mice showed citoplasmic
staining for ALDH. B. Focal expression of ALDH was detected in adherent cells implants (original magnification 6200).
doi:10.1371/journal.pone.0021320.g008
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expression of a well defined set of known markers such as ALDH,
Oct4, Nanog, STAT3 and Notch3 by FACS staining or RT-PCR
and found, as expected, that spheroid cultures overexpress these
genes. Secondly we compared by microarray analysis the global
pattern of gene expression of adherent vs spheres and intersected
data obtained from the two selected lung AdenoCa MPEs with
those obtained by microarray analysis of RNA extracted from
adherent vs sheroids of the NCI-H460 cell line. This led to the
identification of a small set of 18 genes which show a common
trend for up- or down-regulation in lung tumor spheres vs
adherent cultures. A preliminary validation was performed
successfully on a subset of 8 genes using RT-PCR. At this stage
a complete validation of the entire set of 18 genes by RNA and
protein analysis on the same and additional MPE samples is
necessary to increase our confidence on the small signature we
have identified. It is important to point out that some of the genes
present in our small lung spheroid signature have been recently
reported to be involved directly or indirectly in lung tumorigenesis.
This is the case for example of FZD4 and SCD-1. FZD4 is one of
the frizzled receptors responsible for signal transduction of Wnt/b-
catenin pathway. Indeed Wnt/b-catenin signalling has been
shown to potentiate cancer stem cell behaviour in lung cancer
A549 cells [37]. With respect to SCD1, an enzyme responsible for
the synthesis of monounsaturated fatty acids, there is mounting
evidence that lipid perturbations are a common feature of cancer
and cancer cells display a high rate of fatty acid synthesis propelled
by excel substrates supplied by active glycolysis. Indeed, Scaglia et
al have recently shown that reduction of SCD1 expression in lung
cancer cells significantly delays tumor formation and growth rate
in mouse xenografts [38]. Therefore, our profiling studies provides
a short list of genes as promising candidates for studies directed to
assess their functional contribution to spheroid formation and in
vivo tumorigenicity. Albeit preliminary, we have indeed observed
that knocking down expression of these two genes significantly
impairs spheroid formation in vitro (AN, CDV and RM,
unpublished observations).
In response to the last question we observed a high efficiency of
tumor engraftment with p6 cells from the two selected samples
when implanted into NOD/SCID mice. To our opinion this
represents an outstanding rate of uptake, also in the light of our use
of recipient NOD/SCID mice, which are known not to provide
the most permissive environment for CSC transplantation as
compared to NOD/SCID/IL2Rc null mice [39]. Furthermore in
two out of two cases tested we obtained secondary tumors, which
also showed a much shorter latency time than the respective
primary tumors (Table 5). Importantly, the tumor histology and
the immunohistochemistry carried out with a limited number of
markers indicates that tumors developing in mice closely resemble
the original primary human tumor, albeit with some differences.
This demonstrates that tumor cells grown in culture have not
undergone significant deviation.
It is somehow surprising that within the same sample (PEd/10
or PE e/10) the rate of engraftment was similar when comparing
spheroids vs adherent cultures. This is in apparent contrast with
the observation that, at least in our initial survey of known markers
commonly associated with stemness, these were significantly
enriched in spheroids. Indeed, in the case of ALDH expression,
we observed that tumors obtained upon inoculation of spheroids
maintained a higher staining for ALDH than tumors obtained
after inoculation of adherent cells. It is possible, therefore, that in
order to detect more subtle differences between spheroids and
adherent cultures in their uptake efficiency it will be necessary to
conduct in vivo limiting dilution assays. This will deserve further
analysis as well as a thorough understanding of the preliminary
finding that only spheroids but not adherent cultures gave rise to
tumors when injected orthotopically.
In conclusion we have shown here that MPEs are an excellent
source of tumor initiating cells in lung AdenoCa. Bulk cultures can
be utilized to identify genes linked with sphere formation in vitro
and enhanced tumor propagation in vivo.
Supporting Information
Figure S1 Sphere assays, self renewal ability of primary lung
cancer cell.
(TIF)
Figure S2 NOD/SCID mice subcutaneous tumor growth.
(TIF)
Figure S3 IPA Canonical Pathways.
(TIF)
Table S1 Enriched GO terms and filtered by the Hypergeo-
metric test and corrected using False Discovery Rate (FDR).
(TIF)
Table S2 Cluster, containing 69 probesets, was functionally
annotated by Gene Ontology (GO) for Biological Process.
(TIF)
Table S3 69 probesets expression profile over time.
(TIF)
Table S4 Differential expressed probe sets of 82 genes in
adherent vs spheres cell cultures.
(TIF)
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